The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trials

• Gao Chanchan,

  Roles Writing – original draft

  Affiliation Department of Oncology, Zhongda Hospital of Southeast University, Nanjing, China

  ⨯
• Su Xiangyu,

  Roles Methodology

  Affiliation Department of Oncology, Zhongda Hospital of Southeast University, Nanjing, China

  ⨯
• Shi Fangfang,

  Roles Methodology, Writing – review & editing

  Affiliation Department of Oncology, Zhongda Hospital of Southeast University, Nanjing, China

  ⨯
• Chen Yan,

  Roles Methodology, Writing – review & editing

  Affiliation Department of Oncology, Zhongda Hospital of Southeast University, Nanjing, China

  ⨯
• Gu Xiaoyi

  Roles Project administration

  * E-mail: xy_gu@sohu.com

  Affiliation Department of Oncology, Zhongda Hospital of Southeast University, Nanjing, China

  http://orcid.org/0000-0002-6264-0949

  ⨯